MDC1 Cleavage by Caspase-3: a Novel Mechanism for Inactivating the DNA Damage Response During Apoptosis
Total Page:16
File Type:pdf, Size:1020Kb
Published OnlineFirst December 8, 2010; DOI: 10.1158/0008-5472.CAN-10-3297 Cancer Molecular and Cellular Pathobiology Research MDC1 Cleavage by Caspase-3: A Novel Mechanism for Inactivating the DNA Damage Response during Apoptosis Stephanie Solier and Yves Pommier Abstract Recently, we identified the "apoptotic ring," containing phosphorylated histone H2AX (g-H2AX), as an early chromatin modification during apoptosis. Because g-H2AX initiates the DNA damage response (DDR), we tested whether the apoptotic H2AX response leads to the full recruitment of the DDR factors that normally coordinate DNA repair and cell-cycle checkpoints. We show that the apoptotic H2AX response does not recruit the DDR factors because MDC1 (mediator of DNA damage checkpoint protein 1), which normally binds to g-H2AX in response to DNA damage and amplifies the DDR, is cleaved by caspase-3. This cleavage separates the BRCT and FHA domains of MDC1 and constitutes a novel mechanism for the inactivation of DNArepairinapoptoticcells.Also, we show that downregulation of MDC1 increases the apoptotic response to TRAIL. Together, these results implicate MDC1 in the cellular apoptotic response. Cancer Res; 71(3); 1–8. Ó2010 AACR. Introduction We recently identified the "apoptotic ring" as the nuclear peripheral staining of phosphorylated histone H2AX Apoptosis (programmed cell death) is required in multi- (g-H2AX; refs. 8, 9). The g-H2AX apoptotic ring forms in cellular organisms for organ formation, elimination of the early phase of the apoptotic response to a broad range damaged or harmful cells, and maintenance of tissue home- of stimuli including TRAIL. g-H2AX (histone H2AX phos- ostasis. Disruption of the equilibrium between cell death and phorylated on serine 139 by ATM, ATR, and DNA-PK) is proliferation leads to tumor formation when cells divide faster otherwise a fundamental chromatin response to DNA dou- than they die (1). Caspases, a family of cysteine proteases that ble-strand breaks (10), serving as a molecular platform for cleave and inactivate a broad range of cellular proteins, have the docking of protein complexes to chromatin and the been identified as the central effectors of apoptosis (2, 3). amplification the DNA damage response (DDR) and DNA One promising approach for cancer therapy is the develop- repair (10, 11). Direct binding of MDC1 (mediator of DNA ment of targeted agents that selectively kill tumor cells by damage checkpoint protein 1) to g-H2AX via the MDC1 activating caspases. One such agent is recombinant human BRCT (breast cancer C-terminal) domain (12) is essential Apo2L/TRAIL (TNF-related apoptosis-inducing ligand), a for DDR because it leads to the subsequent recruitment and proapoptotic agonist that activates the membrane death assembly of DDR protein complexes including 53BP1 that receptors DR4 and DR5. Human endogenous TRAIL is repair DNA and regulate cell-cycle checkpoints (13, 14). expressed by immune cells as a 281-amino acid polypeptide Recruitment of MDC1 at DNA damage sites is critical for involved in the innate immune response, autoimmunity, and the efficient activation of the intra S-phase checkpoint (15). tumor immunosurveillance (4–6). Recombinant Apo2L/TRAIL MDC1 couples DNA double-strand break recognition by is presently in phase II clinical trials against lymphomas and Nbs1 (a member of the MRN complex containing Mre11, non–small cell lung cancers (7). Rad50, and Nbs1) with its H2AX-dependent chromatin À À retention (16). Accordingly, MDC1 / mice recapitulate À À the phenotype of the H2AX / mice, including growth Authors' Affiliation: Laboratory of Molecular Pharmacology, Center for retardation, male infertility, immune defects, chromosome Cancer Research, National Cancer Institute, Bethesda, Maryland instability, DNA repair defects, and radiation sensitivity Note: Supplementary data for this article are available at Cancer Research (17). Online (http://cancerres.aacrjournals.org/). The focus of the present study was to determine whether Corresponding Author: Yves Pommier, Laboratory of Molecular Phar- macology, Bldg. 37, Rm. 5068, Center for Cancer Research, National the apoptotic g-H2AX response (apoptotic g-H2AX ring; Cancer Institute, NIH, Bethesda, MD 20892. Phone: 301-496-5944; Fax: refs. 8, 9) is associated with the recruitment of the DDR 301-402-0752; E-mail: [email protected] complexes and the role of MDC1 and phosphorylation doi: 10.1158/0008-5472.CAN-10-3297 of H2AX at its C-terminal tyrosine 142 (18–20) in that Ó2010 American Association for Cancer Research. process. www.aacrjournals.org OF1 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 2010 American Association for Cancer Research. Published OnlineFirst December 8, 2010; DOI: 10.1158/0008-5472.CAN-10-3297 Solier and Pommier Materials and Methods Plasmid vector The GFP-MDC1 construct used has been previously Chemicals described (21). Recombinant human soluble TRAIL was obtained from Alexis (Axxora). Anti-Fas was purchased from Upstate. Camp- Immunofluorescence microscopy tothecin and cisplatin were from Sigma-Aldrich. The broad- Cells were washed with PBS, fixed with 2% formaldehyde in spectrum caspase inhibitor Z-VAD-fmk (z-Val-Ala-DL-Asp- PBS for 20 minutes, washed with PBS, postfixed and permea- fluoromethylketone) was from Bachem and the proteasome bilized with cold (À20 C) 70% ethanol for 20 minutes, washed inhibitor MG132 from Sigma-Aldrich. with PBS, blocked with 8% bovine serum albumin (BSA) in PBS for 1 hour, washed with PBS, incubated with the first antibody Cell lines (PT2609-DNA-PK, 1/250 dilution; g-H2AX, 1/500 dilution; PY142- Human colon carcinoma HCT116 and leukemic Jurkat cell H2AX, 1/250 dilution; MDC1, 1/200 dilution) in 1% BSA in PBS lines were obtained from American Type Culture Collection. for 2 hours, washed with PBS, incubated with secondary Normal human prostate epithelial PrEC cell line was obtained antibody conjugated with Alexa Fluor 488 or 568 for 1 hour, from Lonza. washed with PBS, and mounted by using Vectashield mount- ing medium (Vector Laboratories). Confocal images were Western blotting and antibodies sequentially acquired with Zeiss AIM software on a Zeiss Cells were washed twice in PBS and lysed at 4C in buffer LSM 510 NLO Confocal system (Carl Zeiss Inc.). containing 1% SDS (sodium dodecyl sulfate), 10 mmol/L Tris- HCl, pH 7.4, supplemented with protease inhibitors (Roche Sub-G1 analysis Applied Science) and phosphatase inhibitors (Sigma-Aldrich). Cells were washed with PBS, fixed, and permeabilized with Viscosity of the samples was reduced by brief sonication. Equal cold (À20 C) 70% ethanol overnight. The next day, cell pellets amounts of proteins were boiled for 5 minutes in Tris-glycine- were washed again with PBS, resuspended in PBS buffer SDS sample buffer (Invitrogen) or heated at 70C for 10 minutes containing 0.2% NP40 and 0.5 mg/mL of RNase A, incubated in LDS (lithium dodecyl sulphate) sample buffer (Invitrogen), at room temperature for 15 minutes, and put on ice 10 separated by Tris-glycine or Tris-acetate polyacrylamide gels minutes before the addition of 50 mg/mL of propidium iodide. (Invitrogen) and electroblotted onto nitrocellulose membranes DNA content was determined with a FACScan flow cytometer (Bio-Rad). The membranes were saturated with milk, incu- (Becton Dickinson) and quantified with CellQuest software bated overnight at 4C with primary antibodies, washed, and (Becton Dickinson). then incubated for 45 minutes with secondary antibodies: peroxidase-conjugated goat anti-mouse IgG or peroxidase- Site-directed mutagenesis conjugated goat anti-rabbit IgG (Santa Cruz Biotechnology). Point mutations were introduced into the MDC1 expression Signals were revealed by autoradiography with the Enhanced vector with the "QuickChange Lightning Site-Directed Muta- Chemiluminescence Detection Kit (Pierce). genesis kit" (Stratagene) according to the manufacturer's Primary antibodies used were as follows: anti-caspase-2 instructions. MDC1 expression vector was used with the (551094; BD Biosciences), anti-PT2609-DNA-PK (ab18356; relevant oligonucleotides, and PCR was carried out for 18 Abcam), anti-GAPDH (glyceraldehyde 3-phosphate dehydro- cycles. Mutations were confirmed by sequencing. Primers genase; 2118; Cell Signaling), anti-g-H2AX (05-636; Upstate), used for mutagenesis are listed as follows: anti-PY142-H2AX (07-1590; Millipore), anti-H2AX (07-627; 0 0 Upstate), anti-MDC1 (ab11169; Abcam), and anti-tubulin Sequence (5 to 3 ) (MS-581; Lab Vision). D173A sense ctcggaggaggaagtagcttttctttctgaaaggc D173A antisense gcctttcagaaagaaaagctacttcctcctccgag Short interfering RNA D219A sense ccttcaatttgaacagtgccacagatgtggaagaagg Short interfering RNA (siRNA) targeting MDC1 was D219A antisense ccttcttccacatctgtggcactgttcaaattgaagg obtained from Dharmacon (SMARTpool, catalogue number D261A sense gaaatccagcttgaaaaggctcagcctttag- M-003506-04-0005). Negative control siRNA was obtained tgaaggag from Ambion (catalogue number AM4635). Cells were seeded D261A antisense ctccttcactaaaggctgagccttttcaagctggatttc in 6-well plates at a density of 50,000 cells per well 16 hours D683A sense gtgggtgggaccaaggcctctgaagacaactat before transfection. For each sample, 500 pmoles of siRNA D683A antisense atagttgtcttcagaggccttggtcccacccac were mixed with 250 mL of Optimem (Invitrogen; mix A). Five D686A sense gaccaaggactctgaagccaactatggtgattctg microliters of Lipofectamine 2000 (Invitrogen) was mixed with D686A antisense cagaatcaccatagttggcttcagagtccttggtc 250 mL of Optimem and incubated for 5 minutes at room D690-693-695A